Bausch Health Companies Inc.
NYSE · Healthcare · Pharmaceutical Preparations · Quebec, Quebec, Canada
BHC chart
What traders are saying about $BHC
Latest postsBausch Health Companies Inc. news
- Bausch Health Companies Inc. (BHC) stock price, news, quote and history
Yahoo Finance UK ·
- How Is Bausch Health (TSX:BHC) Handling Its Portfolio Operations?
Kalkine Media ·
- Bausch Health Companies Inc. expected to post earnings of $1.25 a share - Earnings Preview
TradingView ·
- BHC Q3 Earnings Preview: Here's What You Should Know
Yahoo Finance ·
- Total current liabilities of Bausch Health Companies Inc. – FWB:BVF
TradingView ·
- Bausch Health Companies Stock Price Forecast. Should You Buy BHC?
StockInvest.us ·
- Will Bausch Health (TSX:BHC) Translate Strategy Into Better Performance?
Kalkine Media ·
- Bausch Health Companies (TSX:BHC): Facts Or Just Headlines Now?
Kalkine Media ·
- Trading the Move, Not the Narrative: (BHC) Edition
Stock Traders Daily ·
- Bausch Health Canada Announces Expanded Public Reimbursement for (Pr)OKEDI® (Risperidone for Extended-Release Injectable Suspension) Across Canada for the Treatment of Schizophrenia
Yahoo Finance ·
- Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway
Yahoo Finance ·
- Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
Yahoo Finance ·
Bausch Health Companies Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $10.27B | $9.63B | $8.76B | $8.12B |
| Net income | $157.0M | -$46.0M | -$592.0M | -$225.0M |
| Diluted EPS | $0.42 | $-0.13 | $-1.62 | $-0.62 |
| Total assets (year end) | $26.37B | $26.52B | $27.35B | $25.69B |
| Cash and equivalents (year end) | $1.31B | $1.18B | $947.0M | $564.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Bausch Health Companies Inc.
- Ticker
- BHC (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Quebec, Quebec, Canada
- Incorporated in
- NJ
- Fiscal year end
- December 31
- SEC CIK
- 885590
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL
Frequently asked questions
What exchange is Bausch Health Companies Inc. listed on?
Bausch Health Companies Inc. trades on the NYSE under the ticker symbol BHC.
What industry is Bausch Health Companies Inc. in?
Bausch Health Companies Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Bausch Health Companies Inc. headquartered?
Bausch Health Companies Inc.'s business address on file with the SEC is in Quebec, Quebec, Canada.
When does Bausch Health Companies Inc.'s fiscal year end?
Bausch Health Companies Inc.'s fiscal year ends on December 31.
How much revenue did Bausch Health Companies Inc. report?
Bausch Health Companies Inc. reported $10.27B in revenue for calendar year 2025, according to its SEC filings.